243 related articles for article (PubMed ID: 30369576)
1. Patient Satisfaction with Direct Oral Anticoagulants and Warfarin.
Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Arima K; Kotani T; Nomoto K; Ikeya Y; Fukushima S; Onikura M; Suzuki Y; Fujita M; Ando H; Ishikawa N; Hirayama A;
Int Heart J; 2018 Nov; 59(6):1266-1274. PubMed ID: 30369576
[TBL] [Abstract][Full Text] [Related]
2. Association of patient satisfaction with direct oral anticoagulants and the clinical outcomes: Findings from the SAKURA AF registry.
Hori K; Okumura Y; Koichi N; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Arima K; Kotani T; Nomoto K; Ohkubo K; Fukushima S; Onikura M; Suzuki Y; Fujita M; Ando H; Ishikawa N; Hirayama A;
J Cardiol; 2020 Jul; 76(1):80-86. PubMed ID: 32089481
[TBL] [Abstract][Full Text] [Related]
3. Psychometric validation of anti-clot treatment scale and treatment satisfaction questionnaire for medication version II in Japanese patients with atrial fibrillation.
Watanabe-Fujinuma E; Banderas BF; Koretsune Y; Kumagai K; Uchiyama S; Yamashita T; Yasaka M; Akiyama S; Briere JB; Dickie G; Cano SJ
J Med Econ; 2019 Aug; 22(8):798-805. PubMed ID: 30995146
[No Abstract] [Full Text] [Related]
4. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
5. [Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants].
Fareau S; Baumstarck K; Farcet A; Molines C; Auquier P; Retornaz F
Geriatr Psychol Neuropsychiatr Vieil; 2015 Mar; 13(1):45-54. PubMed ID: 25786423
[TBL] [Abstract][Full Text] [Related]
6. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.
Perino AC; Shrader P; Turakhia MP; Ansell JE; Gersh BJ; Fonarow GC; Go AS; Kaiser DW; Hylek EM; Kowey PR; Singer DE; Thomas L; Steinberg BA; Peterson ED; Piccini JP; Mahaffey KW
J Am Heart Assoc; 2019 May; 8(9):e011205. PubMed ID: 31023126
[TBL] [Abstract][Full Text] [Related]
8. Patient-Reported Treatment Satisfaction with Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation in China.
Geng YP; Lan DH; Liu N; Du X; Zheng D; Tang RB; Long DY; Yu RH; Sang CH; Bai R; Jiang CX; Li SN; Guo XY; Wang W; Xia SJ; Chang SS; Dong JZ; Chen AH; Ma CS
Thromb Haemost; 2018 Oct; 118(10):1815-1822. PubMed ID: 30235486
[TBL] [Abstract][Full Text] [Related]
9. Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation - Findings From the SAKURA AF Registry.
Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Circ J; 2018 Sep; 82(10):2500-2509. PubMed ID: 30078823
[TBL] [Abstract][Full Text] [Related]
10. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
11. Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.
Baker D; Wilsmore B; Narasimhan S
Intern Med J; 2016 Jul; 46(7):792-7. PubMed ID: 27040617
[TBL] [Abstract][Full Text] [Related]
12. Satisfaction, quality of life and perception of patients regarding burdens and benefits of vitamin K antagonists compared with direct oral anticoagulants in patients with nonvalvular atrial fibrillation.
Contreras Muruaga MDM; Vivancos J; Reig G; González A; Cardona P; Ramírez-Moreno JM; Martí J; Suárez Fernández C;
J Comp Eff Res; 2017 Jun; 6(4):303-312. PubMed ID: 28353372
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.
Obamiro KO; Chalmers L; Lee K; Bereznicki BJ; Bereznicki LRE
Int J Clin Pract; 2018 Mar; 72(3):e13072. PubMed ID: 29457323
[TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
15. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study.
Koretsune Y; Kumagai K; Uchiyama S; Yamashita T; Yasaka M; Watanabe-Fujinuma E; Banderas BF; Akiyama S; Okayama Y; Briere JB; Dickie G; Cano SJ
Curr Med Res Opin; 2018 Dec; 34(12):2157-2164. PubMed ID: 30067119
[TBL] [Abstract][Full Text] [Related]
17. Patients' preferences for new versus old anticoagulants: a mixed-method vignette-based study.
Bajorek B; Saxton B; Anderson E; Chow CK
Eur J Cardiovasc Nurs; 2018 Jun; 17(5):429-438. PubMed ID: 29090608
[TBL] [Abstract][Full Text] [Related]
18. Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis.
You JH
Pharmacogenomics; 2015; 16(10):1089-100. PubMed ID: 26230572
[TBL] [Abstract][Full Text] [Related]
19. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
